# Johns Hopkins University

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/johns-hopkins-university-company
Canonical HTML page: https://getbiobrief.com/entity/johns-hopkins-university-company

## Timeline

- **2026-08-19**: Trump announces Heidi Overton as FDA Commissioner nominee — President Trump names the White House Domestic Policy Council deputy director to lead the FDA, pending Senate confirmation.
- **2026-05**: Marty Makary resigns as FDA Commissioner — The previous FDA head leaves behind unfinished projects on ultraprocessed foods, antidepressants, and COVID-19 shots.

## Recent coverage (1 stories)

### Overton FDA Nomination: 4 Biopharma Risks From Drug Pricing to Vaccines
2026-08-20 00:44:07 · Sentiment: Neutral · Impact: 7/10 · Sources: 2

For biotech and pharma executives, Overton's nomination combines Trump's favored-nation drug pricing push with RFK Jr.'s vaccine skepticism and unfinished reviews of antidepressants and COVID shots. The result could compress margins while opening faster approval pathways for innovation. Investors should watch how she navigates evidence standards and political priorities at the FDA.
Full story: https://getbiobrief.com/story/overton-fda-biopharma-drug-pricing-vaccine-risks

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.